Feature | Stem Cell Therapies | May 08, 2015

Studies Uncover Foundations of Heart Regeneration from Zebrafish

Discovery of regeneration mechanism could lead to method for heart repair in humans

heart regeneration, zebrafish, epicardium, Duke, Poss

May 8, 2015 — While the human heart cannot heal itself, the zebrafish heart can easily replace cells lost by damage or disease. Now, researchers in three recent publications have discovered mysterious properties of the epicardium that could help explain the fish’s remarkable ability to regrow cardiac tissue. The implications may help lead to new therapies for human heart failure or the ability to repair myocardial infarcts. 

After an injury, the cells in the zebrafish epicardium dive into action — generating new cells to cover the wound, secreting chemicals that prompt muscle cells to grow and divide, and supporting the production of blood vessels to carry oxygen to new tissues.

Zebrafish have emerged as an important vertebrate model for cardiovascular research for a number of reasons. This includes their ability to regenerate cardiac tissue if damaged, and because the transparency of the embryos allows easy observation of internal processes like blood vessel development.
 
The first study, in the May 4 issue of the journal Nature, found that when this critical layer of the heart is damaged, the whole repair process is delayed as the epicardium undergoes a round of self-healing before tending to the rest of the heart. The new research showed that the process requires signaling through a protein called sonic hedgehog, and demonstrated that adding this molecule to the surface of the heart can drive the epicardial response to injury.
 
The finding points to a possible target for repairing the damage caused by a heart attack, a major cause of death and disability in the United States. More than 5 million Americans are currently experiencing heart failure, and over 900,000 suffer from a heart attack each year.
 
“The best way to understand how an organ regenerates is to deconstruct it. So for the heart, the muscle usually gets all the attention because it seems to do all the work," said Kenneth D. Poss, Ph.D., senior author of the study and professor of cell biology at Duke University School of Medicine. "But we also need to look at the other components and study how they respond to injury. Clearly, there is something special about the epicardium in zebrafish that makes it possible for them to regenerate so easily."
 
Poss has been studying heart regeneration in zebrafish for the last 13 years. As a postdoctoral fellow he was the first to show that the puny, striped fish could regrow severed pieces of heart tissue, like a lizard growing back a pinched tail. Since then, his group has found that this regeneration involves the input of the epicardium, a thin layer of cells that cover the surface of the heart.
 
“The epicardium is underappreciated, but we think it is important because similar tissues wrap up most of our organs and line our organ cavities,” Poss said. “Some people think of it as a stem cell because it can make more of its own, and can contribute all different cell types and factors when there is an injury. The truth is we know surprisingly little about this single layer of cells or how it works. It is a mystery.”
 
In this study, Poss and his colleagues were determined to identify the regenerative properties of the epicardium. First, Duke postdoctoral fellow Jinhu Wang performed open-heart surgery on live zebrafish, removing approximately one-fifth of the vital organ. Afterwards he used a set of sophisticated genetic tools to kill 90 percent of the epicardial cells and then measured how well the heart healed at various time points. He found that removing this outer layer created a clear lag in regeneration, but that eventually the healing process caught up to that of zebrafish with an intact epicardium.
 
The results suggested that the 10 percent of epicardial cells left behind were able to rebuild the epicardial layer before moving on to heart muscle. Intrigued by the finding, Poss decided to focus the next series of experiments on the epicardium and its ability to regenerate itself. Jingli Cao, another postdoctoral fellow in his laboratory, figured out a way to remove hearts from zebrafish and grow them in dishes in the laboratory, where the tiny two-chambered organs continued to beat and behave as if they were still tucked inside the organism.
 
As they had before, the researchers destroyed most of the heart’s epicardial layer, but this time they put the “explanted” organs under the microscope every day to capture the regeneration in action. They showed that the epicardium regenerated rapidly, covering the heart like a wave from the base of one chamber to the tip of the other in just a week or two. 
 
The researchers then used this model to search for small molecule compounds or drugs that would affect the ability to regenerate. They screened molecules known to be involved in development of embryos, like fibroblast growth factors and sonic hedgehog, and found that the latter was critical for the regeneration process. The researchers now plan to perform larger screens for molecules that could enhance heart repair in zebrafish, and perhaps one day provide a new treatment for humans with heart conditions.
 
In a second paper appearing April 1, 2015, in the journal eLife, Poss and colleagues found that the epicardium produces a molecule called neuregulin that makes heart muscle cells divide in response to injury. When they artificially boosted levels of neuregulin, even without injury, the heart started building more and more muscle cells. The finding further underscores the role of this tissue in heart health.
 
“Studies of the epicardium in various organisms have shown that this tissue is strikingly similar between fish and mammals, indicating that what we learn in zebrafish models has great potential to reveal methods to stimulate heart regeneration in humans,” said Poss.
 
In a separate study of zebrafish, investigators at The Saban Research Institute and the Heart Institute of Children’s Hospital Los Angeles discovered a new source for cells that can develop into coronary vessels and have identified the signaling protein, a chemokine called CXCL12, which guides this process. Results of the study will be published online May 26 by the journal Developmental Cell.
 
Using confocal and time-lapse imaging, the investigators were able to visualize coronary vessels developing from the endocardium, or the inner lining of the heart – specifically from the atrioventricular canal, the structure that divides the heart into compartments.
 
“This furthers our efforts into heart regeneration to repair human hearts,” said Ching-Ling (Ellen) Lien, Ph.D., principal investigator at The Saban Research Institute of CHLA and senior author on the paper. “We have now found a novel source of cells that can differentiate into coronary vessels and have identified the factors required.”
 
Lien and her team observed that zebrafish with a mutation at the CXCR4 receptor survive, but are not able to form coronary vessels or undergo heart regeneration following injury. Since fish without this mutation are able to do both, the investigators concluded that an interaction between CXCR4 receptors on endothelial cells and the CXCL12b protein expressed by the myocardium regulate the process. In addition to providing basic information about the developing heart, this finding may also have clinical relevance.
 
“Children or young adults may not be aware of having abnormal coronary vessels because their circulation is adequate until the heart is stressed by increased demands, for instance when participating in strenuous sports,” explains Lien, who is also an assistant professor at the Keck School of Medicine and an investigator at the Cardiovascular Thoracic Institute, both at the University of Southern California. “Then suddenly, an apparently healthy, young person dies. Alternatively, a person with abnormal coronary vessels might have higher risk of experiencing heart attacks later on in life. Our findings will guide future study toward understanding these devastating conditions in order to be better able to diagnose them and develop interventional strategies.”
 
For more information: www.medschool.duke.edu, www.chla.org
 

Related Content

News | Heart Failure

Heart failure is a rapidly growing public health issue that can be difficult to manage on a global scale. But there are ...

Home October 02, 2024
Home
News | Heart Failure

Sept. 30, 2024 — Cytokinetics, Inc. recently announced that additional analyses synthesizing data from SEQUOIA-HCM ...

Home October 02, 2024
Home
News | Heart Failure

Sept. 18, 2024 – Astellas Pharma Inc. recently announced that Digitiva, a non-invasive digital health solution for heart ...

Home September 19, 2024
Home
News | Heart Failure

Aug. 21, 2024 — The incidence rate of heart failure was 2- to 3-fold higher among American Indian populations than rates ...

Home August 21, 2024
Home
News | Heart Failure

July 31, 2024 — A novel study co-authored by a heart failure cardiologist at University Hospitals Harrington Heart & ...

Home July 31, 2024
Home
News | Heart Failure

July 30, 2024 — Patients with congestive heart failure (CHF) having a compromised blood supply, are at greater risk of ...

Home July 30, 2024
Home
News | Heart Failure

July 29, 2024 — When it comes to treating cardiac arrest, acting quickly can mean the difference between life and death ...

Home July 29, 2024
Home
News | Heart Failure

June 27, 2024 — The human body has sophisticated defenses against the deposition of calcium minerals that stiffen heart ...

Home June 27, 2024
Home
News | Heart Failure

June 24, 2024 — Endotronix, Inc., a privately held company dedicated to advancing the treatment of heart failure (HF) at ...

Home June 24, 2024
Home
News | Heart Failure

June 18, 2024 — As we commemorate Juneteenth 2024, JACC, the flagship journal of the American College of Cardiology, has ...

Home June 18, 2024
Home
Subscribe Now